Biotech and biopharma sectors

16^th International Conference on Biosimilars and Pharmaceuticals & 3^rd Worldwide Forum on Alzheimer and Dementia12^th International Conference on Epidemiology & Public Health

June 23-24, 2023 | Paris, France

Andreu Soldevila Fabrega

LeanBio, Spain

Scientific Tracks Abstracts: J Biomed Pharm Sci

Abstract :

A biopharmaceutical, also known as a biological medical product (or) biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy. Biologics can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living cells or tissues. They (or) their precursors or components) are isolated from living sources human, animal, plant, fungal, or microbial. They can be used in both human and animal medicine.’

Biography :

Andreu Soldevila Fabrega is completed his PhD in Biology, MsC in Biotechnology, MsC in Microbiology and Genètics, MsC in Environmental sciences, BS in Biology and BS in Biotechnology with 16 years of experience in the biotechnology and bio-pharmaceutical industry. He was developed as a professional in the area of small molecules, peptides, biotherapeutics and in the last years specially in New Biological entities and Biosimilars. Professionally, He is interested in functions related to science and business (research and development, business development, technology transfer, project management) in the biotech and biopharma sectors.